SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-018897
Filing Date
2021-04-15
Accepted
2021-04-15 06:50:28
Documents
16
Period of Report
2021-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K reta-8k_20210415.htm   iXBRL 8-K 50163
2 EX-10.1 reta-ex101_49.htm EX-10.1 146571
3 EX-10.2 reta-ex102_50.htm EX-10.2 145625
4 EX-99.1 reta-ex991_130.htm EX-99.1 17645
5 GRAPHIC gtycl1jpndtx000001.jpg GRAPHIC 5631
  Complete submission text file 0001564590-21-018897.txt   563534

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA reta-20210415.xsd EX-101.SCH 5772
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20210415_lab.xml EX-101.LAB 18732
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20210415_pre.xml EX-101.PRE 11170
9 EXTRACTED XBRL INSTANCE DOCUMENT reta-8k_20210415_htm.xml XML 3428
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 21827248
SIC: 2834 Pharmaceutical Preparations